EISAI TO PRESENT DATA ON ROBUST NEUROLOGY PORTFOLIO AT THE 76th AMERICAN ACADEMY OF NEUROLOGY® (AAN) ANNUAL MEETING
Testing for ApoE ε4 status should be performed prior to initiation of treatment to inform the risk of developing ARIA.
- Testing for ApoE ε4 status should be performed prior to initiation of treatment to inform the risk of developing ARIA.
- Depending on ARIA severity, use clinical judgment in considering whether to continue dosing, temporarily discontinue treatment, or permanently discontinue LEQEMBI.
- There is no experience in patients who continued dosing through symptomatic ARIA-E or through asymptomatic, but radiographically severe, ARIA-E.
- There is limited experience in patients who continued dosing through asymptomatic but radiographically mild to moderate ARIA-E.